This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Novavax Inc. slipped 5.8% to $7.91 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.5% to 23,834.72 and the Dow Jones Industrial Average falling 0.5% to 47,336.68.
This was the stock's second consecutive day of losses.
Novavax Inc. closed 31.5% below its 52-week high of $11.55, which the company reached on January 7th.
The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.4% to $186.26, Pfizer Inc. remained unchanged, and Merck & Co. Inc. fell 4.06% to $82.49.
Trading volume totaled 4.3 million, compared to the 50-day average of 4.9 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 03, 2025 16:34 ET (21:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.